You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
北陸藥業(300016.SZ)預計無法在6月2日前完成2019年度權益分派
格隆匯 05-29 16:54

格隆匯5月29日丨北陸藥業(300016.SZ)公佈,公司於2020年4月2日召開2019年度股東大會,審議通過了《2019年度利潤分配預案》,公司擬以2019年12月31日總股本494,689,876股扣除擬回購的股份13.54萬股後的股本494,554,476股為基數,向全體股東每10股派發現金股利0.70元人民幣(含税),共分配現金股利約3461.88萬元,剩餘未分配利潤結轉以後年度。按照《深圳證券交易所創業板股票上市規則》第11.4.5條的規定,上市公司應當在股東大會審議通過方案後兩個月內,完成利潤分配及轉增股本事宜。公司現已備足此次權益分派所需的資金。

《2019年度利潤分配預案》需完成限制性股票回購註銷後才可進行權益分派。因限制性股票回購註銷尚未完成股東大會審議程序,因此,公司預計無法在2020年6月2日前完成2019年度權益分派。

為維護廣大投資者尤其是中小投資者的利益,公司將盡快完成限制性股票回購註銷事項,並向中國證券登記結算有限責任公司深圳分公司申請2019年度權益分派。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account